The ApoE allele variation is implicated in many common illnesses including cognitive decline measured by MMSE and AD (41), and there is a synergistic effect between ApoE4 carrier status and cognitive status in relation to mortality (42). This evidence concerns the gene APOE and Alzheimer disease.